GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 59 filers reported holding GT BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,948 | -22.7% | 8,078 | 0.0% | 0.00% | – |
| Q2 2023 | $2,520 | -43.3% | 8,078 | 0.0% | 0.00% | – |
| Q1 2023 | $4,443 | -35.8% | 8,078 | +3.4% | 0.00% | – |
| Q4 2022 | $6,918 | +38.4% | 7,811 | +119.1% | 0.00% | – |
| Q3 2022 | $5,000 | -98.8% | 3,565 | -97.3% | 0.00% | – |
| Q2 2022 | $400,000 | -47.9% | 134,043 | -49.8% | 0.00% | – |
| Q1 2022 | $768,000 | -43.1% | 266,914 | -39.7% | 0.00% | – |
| Q4 2021 | $1,350,000 | -20.6% | 442,794 | +75.5% | 0.00% | – |
| Q3 2021 | $1,701,000 | +215.0% | 252,291 | +624.1% | 0.00% | – |
| Q2 2021 | $540,000 | +2900.0% | 34,840 | +1235.9% | 0.00% | – |
| Q1 2021 | $18,000 | – | 2,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |